Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 459

1.

Should S-1 be better than capecitabine for patients with advanced gastric cancer in Asia? A systematic review and meta-analysis.

Ye Z, Chen J, Rao Y, Yang W.

Onco Targets Ther. 2018 Dec 27;12:269-277. doi: 10.2147/OTT.S187815. eCollection 2019.

PMID:
30643425
2.

The Efficacy and Safety of (Neo)Adjuvant Therapy for Gastric Cancer: A Network Meta-analysis.

van den Ende T, Ter Veer E, Machiels M, Mali RMA, Abe Nijenhuis FA, de Waal L, Laarman M, Gisbertz SS, Hulshof MCCM, van Oijen MGH, van Laarhoven HWM.

Cancers (Basel). 2019 Jan 11;11(1). pii: E80. doi: 10.3390/cancers11010080.

PMID:
30641964
3.

S-1 combined with paclitaxel may benefit advanced gastric cancer: evidence from a systematic review and meta-analysis.

Bian NN, Wang Y, Min GT.

Int J Surg. 2019 Jan 12. pii: S1743-9191(18)31703-5. doi: 10.1016/j.ijsu.2018.11.010. [Epub ahead of print] Review.

PMID:
30641155
4.

Conversion Surgery for Unresectable Advanced Gastric Cancer: A Systematic Review and Meta-Analysis.

Du R, Hu P, Liu Q, Zhang J.

Cancer Invest. 2019 Jan 11:1-13. doi: 10.1080/07357907.2018.1551898. [Epub ahead of print]

PMID:
30632817
5.

ASSOCIATION OF INTERLEUKIN-10 -592A>C AND -819T>C POLYMORPHISMS WITH GASTRIC CANCER RISK: A SYSTEMATIC REVIEW AND META-ANALYSIS OF 44 CASE-CONTROL STUDIES.

Moghmi M, Arjmandi A, Aghili K, Jafari M, Zare-Shehneh M, Rastegar S, Abolbaghaei SM, Neamatzadeh H.

Arq Bras Cir Dig. 2019 Jan 7;32(1):e1415. doi: 10.1590/0102-672020180001e1415. English, Portuguese.

6.

Endoscopic submucosal dissection of papillary adenocarcinoma of stomach; protocol for a systematic review and meta-analysis.

Bang CS, Choi JH, Lee JJ, Baik GH.

Medicine (Baltimore). 2018 Dec;97(52):e13905. doi: 10.1097/MD.0000000000013905. Review.

7.

Simulation Models in Gastric Cancer Screening: A Systematic Review

Matsuda A, Saika K, Tanaka R, Ito Y, Fukui K, Kamo KI.

Asian Pac J Cancer Prev. 2018 Dec 25;19(12):3321-3334. Review.

8.

Predictive Value of Two Polymorphisms of ERCC2, rs13181 and rs1799793, in Clinical Outcomes of Chemotherapy in Gastric Cancer Patients: A Meta-Analysis.

Li M, Zhao Y, Zhao E, Wang K, Lu W, Yuan L.

Dis Markers. 2018 Nov 19;2018:3947626. doi: 10.1155/2018/3947626. eCollection 2018. Review.

9.

Endoscopic submucosal dissection of early gastric cancer with mixed-type histology: Protocol for a systematic review and meta-analysis.

Bang CS, Choi JH, Yang YJ, Lee JJ, Baik GH.

Medicine (Baltimore). 2018 Dec;97(51):e13838. doi: 10.1097/MD.0000000000013838.

10.

Impact of body mass index on short-term outcomes of laparoscopic gastrectomy in Asian patients: A meta-analysis.

Chen HK, Zhu GW, Huang YJ, Zheng W, Yang SG, Ye JX.

World J Clin Cases. 2018 Dec 6;6(15):985-994. doi: 10.12998/wjcc.v6.i15.985.

11.

A meta-analysis of the effect of microRNA-34a on the progression and prognosis of gastric cancer.

Li Z, Liu ZM, Xu BH.

Eur Rev Med Pharmacol Sci. 2018 Dec;22(23):8281-8287. doi: 10.26355/eurrev_201812_16525.

PMID:
30556868
12.

Influence of thermal ablation of hepatic metastases from gastric adenocarcinoma on long-term survival: Systematic review and pooled analysis.

Tang K, Liu Y, Dong L, Zhang B, Wang L, Chen J, Chen G, Tang Z.

Medicine (Baltimore). 2018 Dec;97(49):e13525. doi: 10.1097/MD.0000000000013525.

13.

The clinical outcomes of S-1 plus cisplatin for patients with advanced gastric cancer: A meta-analysis and systematic review.

Yang L, Wang X, Wang B, Chao P, Li D, Chai C.

Medicine (Baltimore). 2018 Dec;97(49):e12789. doi: 10.1097/MD.0000000000012789.

14.

Minimally invasive and open gastrectomy for gastric cancer: A protocol for systematic review and network meta-analysis.

Wang X, Li Z, Chen M, Wu C, Fu Y.

Medicine (Baltimore). 2018 Nov;97(48):e13419. doi: 10.1097/MD.0000000000013419.

15.

Palliative gastrectomy plus chemotherapy versus chemotherapy alone for incurable advanced gastric cancer: a meta-analysis.

Wu P, Wang P, Ma B, Yin S, Tan Y, Hou W, Wang Z, Xu H, Zhu Z.

Cancer Manag Res. 2018 Oct 26;10:4759-4771. doi: 10.2147/CMAR.S179368. eCollection 2018.

16.

The combination of apatinib and S-1 for the treatment of advanced gastric cancer in China: A meta-analysis of randomized controlled trials.

Liu Y, Zhou C, Zhang K, Feng Y, Zhang R.

Medicine (Baltimore). 2018 Nov;97(47):e13259. doi: 10.1097/MD.0000000000013259.

17.

Postoperative morbidity and mortality in patients receiving neoadjuvant chemotherapy for locally advanced gastric cancers: A systematic review and meta-analysis.

Luo H, Wu L, Huang M, Jin Q, Qin Y, Chen J.

Medicine (Baltimore). 2018 Oct;97(43):e12932. doi: 10.1097/MD.0000000000012932. Review.

18.

A systematic review and meta-analysis on the effect of angiogenesis blockade for the treatment of gastric cancer.

Bai ZG, Zhang ZT.

Onco Targets Ther. 2018 Oct 17;11:7077-7087. doi: 10.2147/OTT.S169484. eCollection 2018.

19.

Survival benefits of additional surgery after non-curative endoscopic resection in patients with early gastric cancer: a meta-analysis.

Li D, Luan H, Wang S, Zhou Y.

Surg Endosc. 2018 Nov 5. doi: 10.1007/s00464-018-6570-9. [Epub ahead of print]

PMID:
30397744
20.

Roles of Cyclooxygenase-2 gene -765G > C (rs20417) and -1195G > A (rs689466) polymorphisms in gastric cancer: A systematic review and meta-analysis.

Luo MX, Long BB, Li F, Zhang C, Pan MT, Huang YQ, Chen B.

Gene. 2019 Feb 15;685:125-135. doi: 10.1016/j.gene.2018.10.077. Epub 2018 Nov 1. Review.

PMID:
30391440

Supplemental Content

Loading ...
Support Center